• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mobile prenatal app shown to reduce in-person visits during pregnancy

Bioengineer by Bioengineer
May 2, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

George Washington University physicians found use of the mobile app Babyscripts reduced in-person prenatal care visits while maintaining patient and provider satisfaction

Using the mobile app Babyscripts reduced in-person prenatal care visits while maintaining patient and provider satisfaction, according to research published in JMIR mHealth and uHealth by physician researchers from the George Washington University (GW).

“Prenatal care is one of the most widely utilized preventative health care services, however there is little research on the effectiveness of standard prenatal care,” said Kathryn Marko, MD, first author of the paper and assistant professor of obstetrics and gynecology at the GW School of Medicine and Health Sciences. “We wanted to reevaluate the model for low-risk pregnancies and see if a mobile prenatal app could remove barriers to access and reduce the burden on patients and the health care system.”

Mobile health apps have the potential to transform health care. Studies have shown mobile technology can improve disease management for diabetes self-care activities, HIV infection medication adherence, and sickle cell anemia medication adherence. The research team, led by Marko, hypothesized that mobile health apps could be just as transformative for prenatal care.

The Babyscripts app was built to deliver educational content and remotely monitor blood pressure and weight. The app gave patients information on topics like nutrition and breastfeeding, but also gave patients and providers early warnings about hypertension or abnormal weight gain, which could indicate gestational diabetes, nutritional deficiency, or edema associated with preeclampsia.

Eligible participants were women between ages 18 – 40 years and considered low-risk – a singleton pregnancy with no previous diagnosis of hypertension, diabetes, renal disease, collagen vascular disease, maternal substance abuse, or other previously documented condition that could potentially lead to a poor pregnancy outcome. A total of 88 low-risk patients were enrolled in the study. Patients who used the app saw their OBGYN an average of 7.8 times. Patients who did not use the app saw their OBGYN an average of 10.2 times. There was no statistical difference in patient or provider satisfaction in either group.

“While the results of our study were largely positive, more research is needed to determine the connection between mobile prenatal apps and maternal or fetal outcomes,” said Andrew Meltzer, MD, co-author of the paper and associate professor of emergency medicine at the GW School of Medicine and Health Sciences. “There is a lot more potential for use of mobile prenatal apps for both patients and providers.”

###

In addition to Marko and Meltzer, the GW research team included Nancy D. Gaba, MD, chair of the Department of Obstetrics and Gynecology; Nihar Ganju, MD, director of digital health at Advantia Health; Joshua J. Benham, MD, physician at Sutter West Bay Medical Group; and Lorna M. Richards, MA, clinical research director at Inova Health System.

The paper, “A Mobile Prenatal Care App to Reduce In-Person Visits: Prospective Controlled Trial,” was published in JMIR mHealth and uHealth and is available at https://mhealth.jmir.org/2019/5/e10520/.

Media Contact
Lisa Anderson
[email protected]

Related Journal Article

https://smhs.gwu.edu/news/mobile-prenatal-app-shown-reduce-person-visits-during-pregnancy
http://dx.doi.org/10.2196/10520

Tags: Clinical TrialsFertilityGynecologyHealth CareHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthPublic HealthTechnology/Engineering/Computer Science
Share12Tweet7Share2ShareShareShare1

Related Posts

Sex Differences in Alcohol’s Impact on Brain Dopamine

September 6, 2025

Fecal Transplants: New Hope for Alzheimer’s Treatment

September 6, 2025

CheckMate 77T: Nivolumab Preserves Quality of Life and Mitigates Symptom Worsening in Resectable NSCLC

September 6, 2025

miR-BART19-3p Boosts EBV-Associated Gastric Cancer Growth

September 6, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase II Study Finds Iza-Bren Plus Osimertinib Achieves 100% Response Rate in EGFR-Mutated NSCLC

Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients

COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Enhances Progression-Free Survival in EGFR-Mutated NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.